|
Real-time Estimate
Cboe BZX
20:07:41 31/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.84 USD | -1.72% |
|
+1.02% | -46.51% |
| 08-11 | BofA Securities Adjusts Keros Therapeutics Price Target to $17 From $20 | MT |
| 08-03 | Keros Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KEROS THERAPEUTICS, INC. | Bio Therapeutic Drugs | -1.36% | +1.02% | -46.51% | -30.73% | -67.63% | 219M |  |  |  |
- Stock Market
- Stocks
- KROS Stock
- Charts Keros Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
